BioCorRx Inc.
OTC:BICX
1.2 (USD) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.089 | 0.214 | 0.048 | 0.123 | 0.24 | 0.377 | 0.657 | 0.702 | 0.925 | 1.171 | 0.715 | 0.868 | 0.772 | 0 | 0 | 0 |
| Cost of Revenue
| 0.236 | 0.015 | 0.006 | 0.096 | 0.082 | 0.171 | 0.324 | 0.175 | 0.152 | 0.221 | 0.16 | 0.402 | 0.4 | 0 | 0 | 0 |
| Gross Profit
| -0.147 | 0.199 | 0.042 | 0.027 | 0.159 | 0.206 | 0.334 | 0.526 | 0.773 | 0.95 | 0.555 | 0.466 | 0.371 | 0 | 0 | 0 |
| Gross Profit Ratio
| -1.646 | 0.929 | 0.878 | 0.218 | 0.66 | 0.546 | 0.508 | 0.75 | 0.836 | 0.811 | 0.776 | 0.536 | 0.481 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 0.891 | 1.459 | 1.606 | 4.274 | 1.125 | 0.152 | 0.451 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 2.74 | 2.322 | 2.049 | 3.674 | 2.884 | 0.986 | 0 | 0.024 | 0.013 | 0.005 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0.134 | 0.224 | 0.077 | 0.193 | 0.036 | 0.101 | 0 | 0 | 0 | 0 |
| SG&A
| 2.702 | 3.41 | 3.741 | 3.168 | 4.565 | 4.423 | 2.74 | 2.545 | 2.126 | 3.867 | 2.92 | 1.086 | 0.713 | 0.024 | 0.013 | 0.005 |
| Other Expenses
| 0.005 | -1.762 | -0.772 | -4.387 | -1.062 | 0.007 | 0.034 | 0.03 | 0.125 | 0.135 | 0.136 | 0.002 | 0.002 | -0 | 0 | 0 |
| Operating Expenses
| 3.593 | 3.107 | 4.575 | 3.054 | 4.629 | 4.582 | 3.225 | 2.576 | 2.251 | 4.003 | 3.055 | 1.088 | 0.715 | 0.024 | 0.013 | 0.005 |
| Operating Income
| -3.74 | -2.908 | -4.533 | -3.027 | -4.47 | -4.626 | -2.891 | -2.182 | -5.118 | -3.053 | -2.5 | -0.623 | -0.344 | -0.024 | -0.013 | -0.005 |
| Operating Income Ratio
| -41.945 | -13.601 | -93.899 | -24.689 | -18.606 | -12.282 | -4.398 | -3.109 | -5.534 | -2.607 | -3.497 | -0.717 | -0.445 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -0.031 | -1.468 | -0.678 | -0.479 | -1.578 | -0.249 | -26.815 | -3.722 | 0.452 | -0.075 | -1.337 | -0.262 | -0.065 | 0 | 0 | 0 |
| Income Before Tax
| -3.77 | -4.377 | -5.211 | -3.507 | -6.048 | -6.584 | -29.706 | -5.904 | -4.666 | -3.128 | -3.837 | -0.884 | -0.409 | 0 | 0 | 0 |
| Income Before Tax Ratio
| -42.289 | -20.468 | -107.943 | -28.596 | -25.174 | -17.481 | -45.195 | -8.413 | -5.046 | -2.671 | -5.367 | -1.018 | -0.53 | 0 | 0 | 0 |
| Income Tax Expense
| -0.004 | -0.007 | 0.593 | 0.508 | 1.66 | 0.001 | -37.963 | -4.77 | 0.075 | -0.428 | 0.002 | 0.002 | 0 | 0.023 | 0.013 | 0.005 |
| Net Income
| -3.767 | -4.369 | -5.803 | -4.015 | -7.708 | -6.512 | -29.706 | -5.904 | -4.666 | -3.128 | -3.839 | -0.886 | -0.409 | -0.023 | -0.013 | -0.005 |
| Net Income Ratio
| -42.249 | -20.433 | -120.218 | -32.743 | -32.083 | -17.289 | -45.195 | -8.413 | -5.046 | -2.671 | -5.369 | -1.02 | -0.53 | 0 | 0 | 0 |
| EPS
| -0.45 | -0.61 | -0.89 | -0.75 | -2.19 | -2.6 | -0.13 | -0.035 | -3 | -2.25 | -3.27 | -0.83 | -0.008 | -0.062 | -0.003 | -0.001 |
| EPS Diluted
| -0.45 | -0.61 | -0.89 | -0.75 | -2.19 | -2.6 | -0.13 | -0.035 | -3 | -2.25 | -3.27 | -0.83 | -0.008 | -0.062 | -0.003 | -0.001 |
| EBITDA
| -3.54 | -2.949 | -4.335 | -2.829 | -4.327 | -4.369 | -40.82 | -6.922 | -4.918 | -3.345 | -3.391 | -0.622 | -0.342 | -0.024 | -0.013 | -0.005 |
| EBITDA Ratio
| -39.703 | -13.791 | -89.794 | -23.069 | -18.012 | -11.599 | -62.106 | -9.863 | -5.318 | -2.857 | -4.743 | -0.716 | -0.443 | 0 | 0 | 0 |